Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry

International Journal of Hematology

Volumn 97, Issue 6, 2013, Pages 749-757

  Lee, Jong Wook ^a   Jang, Jun Ho ^b   Kim, Jin Seok ^c   Yoon, Sung Soo ^d   Lee, Je Hwan ^e   Kim, Yeo Kyeoung ^f   Jo, Deog Yeon ^g   Chung, Jooseop ^h   Sohn, Sang Kyun ⁱ  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Chungnam National University   (South Korea)

^h Pusan National University School of Medicine   (South Korea)

ⁱ Kyungpook National University School of Medicine   (South Korea)

Author keywords

Hemolysis; Mortality; Paroxysmal nocturnal hemoglobinuria; Risk factor; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILD; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEMOLYSIS; HUMAN; KOREA; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; SCHOOL CHILD; SYMPTOMATOLOGY; THORAX PAIN; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LACTATE DEHYDROGENASES; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; THROMBOEMBOLISM; THROMBOSIS; YOUNG ADULT;

EID: 84879190677     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1346-4     Document Type: Article

References (33)

1. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;33319:1253-8.
2. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;10612:3699-709.
3. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;734:703-11.
4. Tabbara IA. Hemolytic anemias. Diagnosis and management. Med Clin North Am. 1992;763:649-68.
5. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;29313:1653-62.
6. Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004;833:193-207.
7. Hillmen P, Muus P, Dührsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007;11012:4123-8.
8. Hill A, Rother RP, Wang X, Morris SM Jr, Quinn-Senger K, Kelly R, et al. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2010;1493:414-25.
9. de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;1128:3099-106.
10. Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;11725:6786-92.
11. Kim Y, Lim J, Kim M, Kim Y, Lee JW, Han K. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects. Ann Clin Lab Sci. 2010;403:226-32.
12. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;3506:552-9.
13. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;35512:1233-43.
14. Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;1114:1840-7.
15. Socié G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet. 1996;3489027:573-7.
16. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M. Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome: an overview. J Thromb Haemost. 2007;53:642-5.
17. Kanakura Y, Ohyashiki K, Shichishima T, Okamoto S, Ando K, Ninomiya H, et al. Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial. Int J Hematol. 2011;931:36-46.
18. Hillmen P, Elebute M, Kelly R, Urbano-Ispizua A, Hill A, Rother RP, et al. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol. 2010;858:553-9.
19. Blum SF, Gardner FH. Intestinal infarction in paroxysmal nodturnal hemoglobinuria. N Engl J Med. 1966;274:1137.
20. Doukas MA, DiLorenzo PE, Mohler DN. Intestinal infarction caused by paroxysmal nocturnal hemoglobinuria. Am J Hematol. 1984;161:75-81.
21. Adams T, Fleischer D, Marino G, Rusnock E, Li L. Gastrointestinal involvement in paroxysmal nocturnal hemoglobinuria: first report of electron microscopic findings. Dig Dis Sci. 2002;471:58-64.
22. Hill A, Sapsford RJ, Scally A, Kelly R, Richards SJ, Khurisgara G, et al. Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function. Br J Haematol. 2012;1583:409-14.
23. Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, et al. Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood. 2005;1067:2559-65.
24. Hill A, Rother RP, Hillmen P. Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal haemoglobinuria. Haematologica. 2005;9012(Suppl):40.
25. Meyers G, Weitz I, Lamy T, Cahn JY, Kroon HA, Severino B, et al. Disease-related symptoms reported across a broad population of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007;11011:3683.
26. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587-91.
27. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;1261:133-8.
28. Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. Eur J Haematol. 2011;871:37-45.
29. Risitano AM, Rotoli B. Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents. Biologics. 2008;22:205-12.
30. Umans JG, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu Rev Physiol. 1995;57:771-90.
31. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood. 1993;82:1192-6.
32. Weitz IC. Thrombosis in paroxysmal nocturnal hemoglobinuria - insights into the role of complement in thrombosis. Thromb Res. 2010;125(Suppl 2):S106-7.
33. Weitz IC. Thrombosis in patients with paroxysmal nocturnal hemoglobinuria. Semin Thromb Hemost. 2011;373:315-21.